Han Min Woo
Sungkyunkwan University · 生化学・遺伝学・分子生物学
研究室紹介
Professor Han Min Woo's research lab specializes in synthetic biology and metabolic engineering of cyanobacteria to develop biosolar cell factories for sustainable production of high-value chemicals from CO₂ and sunlight. The lab focuses on engineering photosynthetic microbes to convert carbon dioxide directly into isoprenoids, biofuels, and other industrially relevant compounds through advanced genetic tools and pathway optimization. Key innovations include the development of CRISPRi systems, synthetic gene expression platforms (e.g., SyneBrick vectors), and metabolic pathways for efficient biosynthesis. The lab's work aims to address global challenges in climate change, energy security, and sustainable chemical production.
Research Overview
Research Output Trend
Figures are computed from collected data and may differ slightly.
Selected Papers
15This is the first demonstration of photosynthetic production of amorpha-4,11-diene from CO2 in cyanobacteria and production of squalene in S. elongatus PCC 7942. Our optimized modular OverMEP strain (SeHL33) with either co-expression of ADS or SQS demonstrated the highest production levels of amorpha-4,11-diene and squalene, which could expand the list of farnesyl diphosphate-derived isoprenoids from CO2 as bio-solar cell factories.
Myrcene, a monoterpene (C10), has gathered attention as a starting material for high-value compounds, such as geraniol/linalool and (-)-menthol. Metabolic engineering has been successfully applied to produce monoterpenes, such as pinene and limonene, at high levels in microbial hosts. However, microbial synthesis of myrcene has not yet been reported. Thus, we metabolically engineered Escherichia coli for production of myrcene by introducing a heterologous mevalonate pathway and overexpressing ta
In cyanobacteria, metabolic engineering using synthetic biology tools is limited to build a biosolar cell factory that converts CO<sub>2</sub> to value-added chemicals, as repression of essential genes has not been achieved. In this study, we developed a dCas12a-mediated CRISPR interference system (CRISPRi-dCas12a) in cyanobacteria that effectively blocked the transcriptional initiation by means of a CRISPR-RNA (crRNA) and 19-nt direct repeat, resulting in 53-94% gene repression. The repression
Cyanobacteria are oxygenic photosynthetic prokaryotes that are able to assimilate CO<sub>2</sub> using solar energy and water. Metabolic engineering of cyanobacteria has suggested the possibility of direct CO<sub>2</sub> conversion to value-added chemicals. However, engineering of cyanobacteria has been limited due to the lack of various genetic tools for expression and control of multiple genes to reconstruct metabolic pathways for biochemicals from CO<sub>2</sub>. Thus, we developed SyneBrick
Capture and conversion of CO2 to valuable chemicals is intended to answer global challenges on environmental issues, climate change and energy security. Engineered cyanobacteria have been enabled to produce industry-relevant chemicals from CO2 . However, the final products from cyanobacteria have often been mixed with fermented metabolites during dark fermentation. In this study, our engineering of Synechococcus elongatus PCC 7942 enabled continuous conversion of CO2 to volatile acetone as sole
High Resolution Image Download MS PowerPoint Slide Direct conversion of carbon dioxide (CO 2 ) to value-added chemicals by engineering of cyanobacteria has received attention as a sustainable strategy in food and chemical industries. Herein, Synechococcus elongatus PCC 7942, a model cyanobacterium, was engineered to produce α-farnesene from CO 2 . As a result of the lack of farnesene synthase (FS) activity in the wild-type cyanobacterium, we metabolically engineered S. elongatus PCC 7942 to expr
The push-and-pull strategy for metabolic engineering was successfully demonstrated in Synechococcus elongatus PCC 7942, a model photosynthetic bacterium, to produce squalene from CO 2 . Squalene synthase (SQS) was fused to either a key enzyme (farnesyl diphosphate synthase) of the methylerythritol phosphate pathway or the β-subunit of phycocyanin (CpcB1). Engineered cyanobacteria with expression of a fusion CpcB1-SQS protein showed a squalene production level (7.16 ± 0.05 mg/L/OD 730 ) that was
BACKGROUND: The construction of microbial cell factories requires cost-effective and rapid strain development through metabolic engineering. Recently, RNA-guided CRISPR technologies have been developed for metabolic engineering of industrially-relevant host. RESULTS: To demonstrate the application of the CRISPR interference (CRISPRi), we developed two-plasmid CRISPRi vectors and applied the CRISPRi in Corynebacterium glutamicum to repress single target genes and double target genes simultaneousl
High Resolution Image Download MS PowerPoint Slide Metabolic engineering of cyanobacteria has received attention as a sustainable strategy to convert carbon dioxide to fatty acid-derived chemicals that are widely used in the food and chemical industries. Herein, Synechococcus elongatus PCC 7942, a model cyanobacterium, was engineered for the first time to produce fatty acid ethyl esters (FAEEs) from CO 2 . Due to the lack of an endogenous ethanol production pathway and wax ester synthase (AftA)